Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silvercorp to Acquire Adventus Creating a Diversified Mining Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Lattice Biologics Ltd V.LBL.H

Alternate Symbol(s):  LBLTF

Healthcare Biotechnology
Lattice Biologics Ltd. is engaged in the business of developing, manufacturing and marketing biologics products to domestic and international markets. The Company’s products are used in a variety of applications including enhancing bone regeneration in dental, spine, and general orthopedic indications. Its acellular dermal matrix is used for dental flaps which is used to close defects post-implantation. The Company’s stem cell-based technology AmnioBoost, is an amniotic fluid concentrate, which can be used to accelerate and enhance bone regeneration for dental post implantation. In addition, its products complimentary to the dental allograft market are amniotic membrane, Demineralized bone matrix (DBM) putty, acellular dermal matrix and cancellous DBM sponges.


TSXV:LBL.H - Post by User

Lattice Biologics Ltd > Just let be...will come back
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(25)
•••
Comment by Gentianon Feb 04, 2022 1:33pm
348 Views
Post# 34398593

RE:RE:RE:RE:RE:RE:RE:Just let be...will come back

RE:RE:RE:RE:RE:RE:RE:Just let be...will come back
I really hope you are right :).  I wonder how much of the overall business was lost because of the bankrupt US subsidiary. In percentage terms, it must be a lot. The Lattice website has not been working for several months now. If they are indeed continuing with their current business (as Guy Cook mentioned: "During the transition period, we remain committed to our Biologics customers and will continue to support our technologies and services"), they really need this working.
 As for their new business, psychedelics and cannabis, there is no news since March 31, 2021. But let's hope...

Here is the link to LBL.H to NEX:
https://apps.tmx.com/TMX/HttpController?GetPage=NEXQuotesViewPage&IsJ2Market=Yes&RowNumber=1&SelectedSymbol=LBL.H&DetailedView=DetailedCompanyInformation&QuoteSymbol_1=LBL.H&QuoteSymbol_2=&QuoteSymbol_3=&QuoteSymbol_4=&QuoteSymbol_5=&QuoteSymbol_6=&QuoteSymbol_7=&QuoteSymbol_8=&QuoteSymbol_9=&QuoteSymbol_10=&QuoteSymbol_11=&QuoteSymbol_12=

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities